Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) -4.4613.37610.65-249.43-

What is the latest EBIT Growth ratio of SOTAC PHARMACEUTICALS ?

The latest EBIT Growth ratio of SOTAC PHARMACEUTICALS is -4.46 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar2024-4.46
Mar202313.37
Mar2022610.65
Mar2021-249.43
Mar2020-

How is EBIT Growth of SOTAC PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2024 -4.46
Negative
Mar2023 13.37
-97.81
Mar2022 610.65
Positive
Mar2021 -249.43
0
Mar2020 0 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare EBIT Growth ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹119.9 Cr -2.7% -13.9% -19.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,936.0 Cr -5.8% -3.2% 35.1% Stock Analytics
DIVIS LABORATORIES ₹152,157.0 Cr -2.8% -3.6% 44.7% Stock Analytics
CIPLA ₹116,200.0 Cr -3.9% -0.5% 13.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,325.0 Cr -1.2% 7.1% 17.8% Stock Analytics
ZYDUS LIFESCIENCES ₹98,037.4 Cr -2.7% -0.1% 40.9% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-2.7%

-13.9%

-19.6%

SENSEX

-2.1%

-6.4%

7%


You may also like the below Video Courses